2.3 Million New Female Breast Cancer Cases Seen Globally in 2022
By Elana Gotkine HealthDay Reporter
MONDAY, Feb. 24, 2025 -- In 2022, there were 2.3 million new breast cancer cases and 670,000 deaths from female breast cancer globally, according to a study published online Feb. 24 in Nature Medicine.
Joanne Kim, Ph.D., from the International Agency for Research on Cancer in Lyon, France, and colleagues examined the current (2022) and future (2050) global burden of female breast cancer overall and by age group in 185 countries and assessed 10-year trends in incidence and mortality rates in 50 and 46 countries, respectively.
The researchers found that in 2022, there were 2.3 million new breast cancer cases and 670,000 deaths from female breast cancer worldwide. In half of examined countries, annual rates increased by 1 to 5 percent. In 29 countries with a very high Human Development Index (HDI), mortality rates decreased, and seven countries are currently meeting the Global Breast Cancer Initiative goal of ≥2.5 percent decrease each year. New cases and deaths are projected to increase by 38 and 68 percent, respectively, by 2050, disproportionately impacting low-HDI countries.
"Sustained investment and improvement in early diagnosis and treatment are also urgently needed, particularly in low- and medium-HDI countries, to reduce growing inequities in breast cancer survival and mitigate poor outcomes for the millions of additional women who will receive a diagnosis of breast cancer in the coming years," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
Helping Others Linked to Higher Level of Cognitive Function
THURSDAY, Aug. 21, 2025 -- Helping others, both via formal volunteering and informal helping, is associated with higher levels of cognitive function and slower cognitive decline...
TAR-200 Monotherapy Promising for BCG-Unresponsive Bladder Cancer
THURSDAY, Aug. 21, 2025 -- For patients with Bacillus Calmette-Guérin (BCG)-unresponsive high-risk non-muscle-invasive bladder cancer (NMIBC), an intravesical...
Work-Related Income Drops for Parents of Children Diagnosed With Type 1 Diabetes
THURSDAY, Aug. 21, 2025 -- Work-related income decreases sharply for mothers and fathers of children diagnosed with type 1 diabetes, with similar effects across sociodemographic...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.